Bcg Vaccine (Tuberculosis) Suppliers & Bulk Manufacturers
Available Forms: Lyophilized powder, Injectable suspension
Available Strengths: 0.1 mL or 0.5 mL
Reference Brands: BCG(US)
Category:
Vaccines
BCG vaccine contains weakened Mycobacterium bovis, stimulating the immune system to produce protection against tuberculosis. It helps prevent severe TB forms like meningitis and disseminated disease in children. Benefits include long-lasting immunity, reduced TB morbidity and mortality, especially in high-risk populations, supporting global TB control efforts.
BCG Vaccine (Tuberculosis) is available in Lyophilized powder, Injectable suspension
and strengths such as 0.1 mL or 0.5 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, BCG Vaccine (Tuberculosis) is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
BCG Vaccine (Tuberculosis) can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
BCG (Bacille Calmette-Guérin) vaccine is approved in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP standards. In the US, BCG approval is limited, mainly used for certain high-risk groups; in the EU, licensed for TB prevention in specific populations. The vaccine undergoes validation, stability testing, and quality audits, with comprehensive documentation including clinical trial data, safety profiles, and manufacturing practices. For licensing procedures, approved dossiers, and latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective TB prevention globally, supporting public health initiatives and high-risk population protection.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing